Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GSTS Pathology Innovation Academy Demonstrates the Impact of Personalized Medicine

Published: Wednesday, December 18, 2013
Last Updated: Wednesday, December 18, 2013
Bookmark and Share
Second Innovation Academy attracts more than 100 delegates to the Royal Institution of Great Britain.

The second Innovation Academy hosted by GSTS Pathology, attracted more than 100 delegates to the Royal Institution of Great Britain on Friday 6th December 2013.

The theme of the symposium - ‘Personalized medicine: today’s reality, not just a promise for tomorrow’, examined advances in three areas - therapeutic drug monitoring, infectious diseases and transplantation, and oncology - with particular recognition of the impact personalized medicine is making in healthcare.

For more than 200 years the Royal Institution of GB has been home to eminent scientists whose discoveries have helped to shape the modern world, making it a particularly inspiring venue for this Innovation Academy event. Speakers included respected scientists and clinicians from across healthcare, industry and GSTS Pathology.

The Innovation Academy aims to support and showcase scientific innovations developed at GSTS and how they can improve patient care now and in the future.

Fiona Carragher, Deputy Chief Scientific Officer for England, opened the meeting by discussing the many challenges facing today’s heath service and how they can be addressed. “Science will be crucial in this, with research constantly informing new ways of working. While personalized medicine has been in use for a long time - for example INR measurement in anticoagulation therapy - it is clear that genomics and personalized medicine continue to be at the forefront of many new techniques.”

Dr Dominic Harrington, Scientific Director, GSTS Pathology, co-organized the symposium. “Personalized medicine isn’t just a theoretical research idea, but offers practical solutions for tailoring and monitoring therapies in a wide variety of clinical conditions, delivering improvements in patient care today. The Innovation Academy aims to create an environment supportive of innovation, quality and the development of our future scientific leaders. We know that good science equals good medicine.”

As the UK’s leading independent provider of pathology services, GSTS Pathology LLP provides a full suite of clinically led pathology services that make a real difference to patient care.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
"Gene Fusion" Drives Childhood Brain Cancers
Study co-led by Penn scientists highlights potential targets for future cancer therapies.
Head Injury Patients Develop Brain Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
New Way to Identify Brain Tumor Aggressiveness
Looking at a brain tumor’s epigenetic signature may help guide therapy.
OncoCyte, The Wistar Institute Enter Global Licensing Agreement
Exclusive rights to commercialize biomarker assay follows years of positive collaboration on lung cancer diagnostic test.
Easier Diagnosis for Fungal Infection of the Lungs
A new clinical imaging method developed in collaboration with a University of Exeter academic may enable doctors to tackle one of the main killers of patients with weakened immune systems sooner and more effectively.
Antibiotic Susceptibility Testing
A team of biologists and biomedical researchers at UC San Diego has developed a new method to determine if bacteria are susceptible to antibiotics within a few hours, an advance that could slow the appearance of drug resistance and allow doctors to more rapidly identify the appropriate treatment for patients with life threatening bacterial infections.
Mitochondrial Troublemakers Unmasked in Lupus
Drivers of autoimmune disease inflammation discovered in the traps of pathogen-capturing white blood cells.
DNA Analysis in the Fast Lane
Rice bioengineers' method should lead to better database of thermal behaviors.
‘Simple Rules’ Calculate Ovarian Cancer Risk
Scientists have formulated a system that uses ultrasound images to accurately work out the likelihood of an ovarian growth being cancerous.
Finding the Needle in a Microbial Haystack
After developing a novel investigational technology called PathoChip that can rapidly identify elusive microorganisms, a team of Penn Medicine researchers recently succeeded for the first time in identifying a pathogen in a patient sample, demonstrating the proof of principle that this technology can be used to identify pathogens in human disease.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!